Applied Genetics

Executive Summary

Applied Genetics Laboratories, Inc. (AGL) is a specialized contract research organization (CRO) based in Cambridge, MA, offering GLP-compliant cytogenetic services including karyotyping and FISH analysis for cell line characterization and species verification. Serving pharmaceutical, biotech, and medical research clients, AGL also supplies research products such as Hybloc™ DNA and human metaphase slides. Founded in 2016, the company operates in the niche but critical field of genetic analysis, supporting preclinical safety and quality control. As a private entity, AGL maintains a stable position in the outsourced research market, with potential for growth driven by increasing demand for genetic testing in drug development. However, its small scale and lack of disclosed funding or high-profile partnerships suggest a moderate conviction for near-term upside.

Upcoming Catalysts (preview)

• TBDExpansion of service offerings to include next-generation sequencing (NGS) support40% success
• TBDNew strategic partnership with a major pharmaceutical company for cell line characterization30% success
• TBDReceipt of ISO 17025 accreditation for expanded laboratory capabilities50% success